Product Details

VERMOXI-D is a sterile ophthalmic solution. It combines an antibiotic and a corticosteroid for combined infection and inflammation control. As a result, ophthalmologists commonly prescribe it for post-surgical and infective-inflammatory eye conditions.

The eye drops combine:

• Moxifloxacin – This fourth-generation fluoroquinolone antibiotic inhibits bacterial DNA gyrase and topoisomerase IV. Consequently, it stops bacterial DNA replication and clears susceptible ocular infections.
• Dexamethasone – This corticosteroid suppresses inflammatory mediators and immune cell activity in ocular tissue. Therefore, it reduces pain, redness, and swelling associated with infection or post-surgical inflammation.

Together, these two agents treat infection and inflammation simultaneously. So, VERMOXI-D suits post-operative eye care, bacterial conjunctivitis with inflammatory involvement, and other conditions where combined antibiotic-steroid therapy is indicated. Because of this, ophthalmologists commonly use it following ocular surgeries and for infective-inflammatory eye conditions.

Key Features

• The formula meets sterility standards for safe ocular use
• Dual-action formula combines antibacterial and anti-inflammatory effects
• The combination suits post-surgical eye care and infective-inflammatory conditions
• A compact 5ml dropper bottle allows accurate, controlled dosing
• The formula suits hospital, clinic, and retail pharmacy distribution
• Physicians can prescribe it confidently for combined infection-inflammation care